Universal Health International Group Holding Limited provided earnings guidance for the six months ended 31 December 2018. For the period, the interim results of the Group is expected to record a significant decrease in loss for the six months ended 31 December 2018 as compared to the loss recorded in the corresponding period in 2017. Details of which will be disclosed in the results announcement to be published in late February 2019. The Board considers that the expected significant decrease in loss recorded for the Period as compared to the loss in the corresponding period in 2017 was mainly due to the following factors: the Group has made an analysis on the impact of the macro and industrial economic environment and performed an impairment assessment on goodwill. Based on that the Group made a provision for impairment loss on goodwill (approximately RMB 288 million) arising on the acquisition of retail and distribution businesses in prior years in the corresponding period in 2017, while there is no provision for impairment loss on goodwill made during the Period; marketing expenses and administrative expenses of the Group during the Period are lower than the corresponding period in 2017.